Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats | |
Liu, Houfu2; Yang, Junling; Du, Feifei; Gao, Xiumei3; Ma, Xutao3; Huang, Yuhong3; Xu, Fang; Niu, Wei; Wang, Fengqing; Mao, Yu | |
刊名 | DRUG METABOLISM AND DISPOSITION |
2009-12 | |
卷号 | 37期号:12页码:2290-2298 |
ISSN号 | 0090-9556 |
DOI | 10.1124/dmd.109.029819 |
文献子类 | Article |
英文摘要 | Panax notoginseng (Sanqi) is a cardiovascular herb containing ginsenosides that are believed to be responsible for the therapeutic effects of Sanqi. The aim of this study was to evaluate rat exposure to ginsenosides after oral administration of Sanqi extract and to identify the key factors affecting their absorption and disposition. Ginsenosides were administered to rats, either in the form of Sanqi extract or as pure chemicals. The ginsenosides Ra-3, Rb-1, Rd, Re, Rg(1), and notoginsenoside R-1 were the major saponins present in the herbal extract. Systemic exposure to ginsenosides Ra-3, Rb-1, and Rd after oral administration of the extract was significantly greater than that to the other compounds. Considerable colonic deglycosylation of the ginsenosides occurred, but the plasma levels of deglycosylated metabolites were low in rats. Poor membrane permeability and active biliary excretion are the two primary factors limiting systemic exposure to most ginsenosides and their deglycosylated metabolites. In contrast with other ginsenosides, biliary excretion of ginsenosides Ra-3 and Rb-1 was passive. Meanwhile, the active biliary excretion of ginsenoside Rd was significantly slower than that of other saponins. Slow biliary excretion, inefficient metabolism, and slow renal excretion resulted in long-circulating and thus relatively high exposure levels for these three ginsenosides. For these reasons, plasma ginsenosides Ra-3, Rb-1, and Rd were identified as pharmacokinetic markers for indicating rat systemic exposure to Sanqi extract. This is a systematic investigation of the absorption and disposition of ginsenosides from an herb, the information gained from which is important for linking Sanqi administration to its medicinal effects. |
资助项目 | National Basic Research Program of China[2005CB523403] ; National Science and Technology Major Project of China[2009ZX09304-002] ; National Science Fund of China for Distinguished Young Scholars[30925044] ; National Natural Science Foundation of China[90209044] ; Shanghai Science and Technology Major Project[08DZ1980200] |
WOS关键词 | TRADITIONAL CHINESE MEDICINE ; 4 ACTIVE SAPONINS ; INTESTINAL BACTERIA ; GINSENG SAPONINS ; HERBAL MEDICINE ; BIOAVAILABILITY ; PERFORMANCE ; METABOLISM ; PLASMA ; EXCRETION |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS |
WOS记录号 | WOS:000271935200004 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/279074] |
专题 | 上海药物代谢研究中心 科研与新药推进处 |
通讯作者 | Li, Chuan |
作者单位 | 1.Chinese Acad Sci, Shanghai Ctr DMPK Res, Shanghai Inst Mat Med, SIBS, Shanghai 201203, Peoples R China; 2.Chinese Acad Sci, Grad Sch, Shanghai 201203, Peoples R China; 3.Tianjin Univ Tradit Chinese Med, Tianjin, Peoples R China; 4.Tianjin Inst Pharmaceut Res, Tianjin State Key Lab Pharmacodynam & Pharmacokin, Tianjin, Peoples R China |
推荐引用方式 GB/T 7714 | Liu, Houfu,Yang, Junling,Du, Feifei,et al. Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats[J]. DRUG METABOLISM AND DISPOSITION,2009,37(12):2290-2298. |
APA | Liu, Houfu.,Yang, Junling.,Du, Feifei.,Gao, Xiumei.,Ma, Xutao.,...&Li, Chuan.(2009).Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats.DRUG METABOLISM AND DISPOSITION,37(12),2290-2298. |
MLA | Liu, Houfu,et al."Absorption and Disposition of Ginsenosides after Oral Administration of Panax notoginseng Extract to Rats".DRUG METABOLISM AND DISPOSITION 37.12(2009):2290-2298. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论